Hera Biotech
PrivateLast Round
Seed Round
Sep 23, 2026
Total Funding Raised
$13.01M
Momentum
Top 10%
of companies Caplight tracks
Company Overview
Hera Biotech is a biotechnology company that develops non-surgical, tissue-based diagnostic tests for the detection and staging of endometriosis.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Precision Medicine, Clinical Trials
Business Model
B2B
Customer Profile
Usage-Based SaaS, Government Contracts
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Hera Biotech Comparables
Compare Hera Biotech with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| DotLab | 87% | |
| HerAnova Lifesciences | 86% | |
| Cicero Diagnostics, Inc. | 84% |
Hera Biotech Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed Round | Sep 23, 2026 | ||||
| Series A | May 3, 2025 | ||||
| Seed | Aug 24, 2022 | ||||
| Grant | Oct 20, 2021 |
Key People
Founding team and executive leadership
Hera Biotech Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| City Side Ventures | Seed |
| Kendra Scott Women's Entrepreneurial Leadership Institute | Seed, Grant |
| Coyote Ventures | Seed |
| Althea | Seed |
| Stella Foundation | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Sep 23, 2026
Raised $2M in Seed funding.
- Jul 24, 2026
Monthly visitors increased 52% MoM, reaching 2.7K.
Hera Biotech Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Hera Biotech's valuation, stock price, and market status.
Is Hera Biotech a public or private company?
Hera Biotech is a private company.
What is the current stock price of Hera Biotech?
Hera Biotech is a private company with no public stock price. No recent secondary market data is available.
How much is Hera Biotech worth (valuation)?
Valuation information for Hera Biotech is not publicly available.
Can I buy Hera Biotech stock?
Hera Biotech shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Hera Biotech's last funding round?
Hera Biotech's most recent funding round was Series A on May 3, 2025.
Who are the main investors in Hera Biotech?
Key investors in Hera Biotech include Kendra Scott Women's Entrepreneurial Leadership Institute, Coyote Ventures, Althea.
Will Hera Biotech IPO soon?
No public IPO plans have been announced for Hera Biotech.
How can I track Hera Biotech secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Hera Biotech's secondary market activity and sign up for updates.